Rangarajan Sampath

Dr. Rangaranjan leads Ibis’ genomics efforts in microbial detection and diagnosis and is responsible for applications development, validation, data analysis and reporting for the Ibis Universal Microbial Detection Platform. His research interests include pathogen discovery, epidemiological surveillance and infectious disease diagnostics. He has been the lead genomics investigator on several programs that are related to bioinformatics, drug discovery and biological-warfare agent detection and treatment and has published over 60 research articles and has 15 patents in related fields. From 1995 to 1997 he was a postdoctoral fellow at the Indiana University School of Medicine where he studied cell signal transduction pathways. He completed his Ph.D. in chemical engineering from Rice University, Texas, USA, in 1995 and B.S. in chemical engineering from the Indian Institute of Technology, Chennai, India in 1989.

A rise in the spread of new diseases, such as Ebola, and the resurgence of diseases that were once considered under control, like malaria, have captured the world’s attention and raised awareness of the risks of infectious disease. Add to this the growing problem of antimicrobial resistance caused by the use and misuse of antimicrobials over the past 70 years, and it is clear that there is an urgent need for the development of new diagnostics and medicines that address the way critical infections are diagnosed and treated.
A few years ago I was attending a conference on biologics manufacturing and the keynote speaker said their industry was lagging in implementing modern microbiological tools whereas the beer industry was way ahead. I was glad there were no clinical microbiologists in the room!